Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02CPP
|
|||
Former ID |
DNCL003781
|
|||
Drug Name |
Vonoprazan
|
|||
Synonyms |
TAK-438
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Helicobacter infection [ICD-11: DA42-DA63; ICD-10: B96.81; ICD-9: 41.86] | Approved | [1] | |
Gastroesophageal reflux disease [ICD-11: DA22.Z] | Phase 3 | [2] | ||
Company |
Takeda
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H20FN3O6S
|
|||
Canonical SMILES |
CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=CC(=O)O)C(=O)O
|
|||
InChI |
1S/C17H16FN3O2S.C4H4O4/c1-19-10-13-9-17(15-6-2-3-7-16(15)18)21(12-13)24(22,23)14-5-4-8-20-11-14;5-3(6)1-2-4(7)8/h2-9,11-12,19H,10H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1+
|
|||
InChIKey |
ROGSHYHKHPCCJW-WLHGVMLRSA-N
|
|||
CAS Number |
CAS 881681-01-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Gastric H(+)/K(+) ATPase (Proton pump) | Target Info | Modulator | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2008 | |||
REF 2 | ClinicalTrials.gov (NCT02388724) Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Patients With Erosive Esophagitis. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.